Hikma Pharmaceuticals (LON:HIK) Shares Pass Above 200-Day Moving Average – What’s Next?

Hikma Pharmaceuticals PLC (LON:HIK)’s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,928.90 ($23.47) and traded as high as GBX 2,102 ($25.57). Hikma Pharmaceuticals shares last traded at GBX 2,091.92 ($25.45), with a volume of 345,375 shares traded.

Hikma Pharmaceuticals Trading Up 1.0 %

The business has a 50 day simple moving average of GBX 1,949.17 and a 200-day simple moving average of GBX 1,928.90. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.48. The stock has a market capitalization of £4.64 billion, a price-to-earnings ratio of 3,218.34, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.